Aflac Advances in Research (AiR) Meeting -"Targeting Cancer Stem Cells Through MPL by Engineered Immunocompetent Cells" & "Gradient-Based, Multi-Drug Resistance Profiling Towards Personalized Outcome Predictions in Pediatric Leukemia"